Nuo Therapeutics, Inc. Cash and Restricted Cash
Nuo Therapeutics, Inc. (AURX) had Cash and Restricted Cash of $400.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $400.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $300.00K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $500.00K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $500.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $500.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $500.00K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $300.00K 10-Q · filed 2025-07-31 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $300.00K 10-K · filed 2025-04-01 |
| 2024-09-30 | $683.84K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $473.04K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $366.23K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $928.68K 10-K · filed 2025-04-01 |
| 2023-09-30 | $637.59K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $399.37K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $2.11M 10-K · filed 2025-04-01 |
| 2022-09-30 | $2.93M 10-Q · filed 2023-11-20 |
| 2022-06-30 | $3.44M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $665.39K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $1.41M 10-K · filed 2024-04-19 |
| 2021-09-30 | $148.43K 10-Q · filed 2022-11-04 |
| 2020-12-31 | $161.43K 10-K · filed 2023-04-17 |